<DOC>
	<DOCNO>NCT01764867</DOCNO>
	<brief_summary>The purpose study compare treatment outcome measurement base Algorithm Guided Treatment Treatment As Usual strategies Chinese population major depressive disorder .</brief_summary>
	<brief_title>Algorithm Guided Treatment Strategies Major Depressive Disorder</brief_title>
	<detailed_description>The AGT arm include 2-step medication monotherapy combination treatment algorithm . The first step ( level 1 ) include two medication monotherapy option : escitalopram mirtazapine . For participant n't remit initial intervention 6 12-week treatment , second step ( level 2 ) variety treatment option provide . In level 2 intervention , switch strategy n't remit escitalopram switched mirtazapine , n't remit mirtazapine switched escitalopram , combination strategy ( i.e . escitalopram plus mirtazapine ) augmentation strategy ( i.e . escitalopram mirtazapine plus either rTMS mECT ) . Participants n't get remission level 1 intervention encourage enter level 2 intervention base intend-to-treatment principle . The TAU arm control intervention perform use psychiatrist 's individual discretion base his/her expertise knowledge . Participants recruit consecutively 8 psychiatric setting across China randomize two initial intervention AGT TAU arm . Follow-up interview perform monthly participant finish acute treatment AGT TAU . The follow-up period last 6 month .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<mesh_term>Mianserin</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Fluvoxamine</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<mesh_term>Trazodone</mesh_term>
	<mesh_term>Mirtazapine</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Meets Diagnostic Statistical Manual Mental Disorders , Fourth Edition ( DSMIV ) criteria single recurrent nonpsychotic major depressive disorder Age 1875 Written inform consent complete Scores 14 high 17item Hamilton Depression Rating Scale Initial treatment escitalopram mirtazapine antidepressant clinically appropriate History bipolar disorder Concurring psychotic disorder Scores 3 high item 3 ( suicidal ) HRSD17 History nonresponse adequate trial escitalopram and/or mirtazapine Has general medical condition , contraindicate leve 1 2 treatment option Is concomitant medication , contraindicate leve 1 2 treatment option Any contraindication mECT rTMS Is pregnant breast feed plan get pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>major depressive disorder</keyword>
	<keyword>algorithm guide treatment</keyword>
	<keyword>treatment usual</keyword>
	<keyword>escitalopram</keyword>
	<keyword>mirtazapine</keyword>
	<keyword>transcranial magnetic stimulation ( rTMS )</keyword>
	<keyword>modify electroconvulsive therapy ( mECT )</keyword>
	<keyword>remission</keyword>
	<keyword>relapse</keyword>
	<keyword>quality life</keyword>
</DOC>